Form 4: UNITED THERAPEUTICS Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Nilda Mesa, a Director of UNITED THERAPEUTICS Corp, sold 228 shares of common stock on September 14, 2026.

Summary

  • Option exercise/conversion: acquired 130 Common Stock at $110.86 ($14,412) on September 14, 2026; holds 6,560 after (Direct).
  • Open-market sale: disposed of 130 Common Stock at $505.79 ($65,752) on September 14, 2026; holds 6,430 after (Direct).
  • Open-market sale: disposed of 98 Common Stock at $505.98 ($49,586) on September 14, 2026; holds 5,580 after (Direct).
  • Option exercise/conversion: disposed of 130 Stock Option on September 14, 2026; holds 6,430 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $115,338 of stock on the open market.

Insider Transactions

Nilda Mesa — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-09-14Option exercise/conversionCommon Stock130$111$14.4K6,560
2026-09-14Open-market saleCommon Stock130$506$65.8K6,430
2026-09-14Open-market saleCommon Stock98$506$49.6K5,580
2026-09-14Option exercise/conversionStock Option130——6,430

Key Dates

DateDescription
2026-09-14Option exercise/conversion (130 shares)
2026-09-14Open-market sale (130 shares)
2026-09-14Open-market sale (98 shares)
2026-09-14Option exercise/conversion (130 shares)

Keywords

insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Nilda Mesa

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.